Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

Lisa Bartmann^{1

2}, David Schumacher², Saskia von Stillfried³, Marieke Sternkopf², Setareh Alampour-Rajabi², Marc A M J van Zandvoort^{2

4}, Fabian Kiessling¹, Zhuojun Wu^{1

2}

Affiliations

¹ Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, Germany.
² Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany.
³ Institute of Pathology, University Clinic, RWTH Aachen University, Aachen, Germany.
⁴ Department of Genetics and Molecular Cell Biology, School for Cardiovascular Diseases (CARIM), School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, Netherlands.

Published Erratum

Lisa Bartmann et al. Front Pharmacol. 2020.

. 2020 Nov 26:11:617329.

doi: 10.3389/fphar.2020.617329. eCollection 2020.

Lisa Bartmann^{1

2}, David Schumacher², Saskia von Stillfried³, Marieke Sternkopf², Setareh Alampour-Rajabi², Marc A M J van Zandvoort^{2

4}, Fabian Kiessling¹, Zhuojun Wu^{1

2}

¹ Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, Germany.
² Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany.
³ Institute of Pathology, University Clinic, RWTH Aachen University, Aachen, Germany.
⁴ Department of Genetics and Molecular Cell Biology, School for Cardiovascular Diseases (CARIM), School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, Netherlands.

Abstract

[This corrects the article DOI: 10.3389/fphar.2019.00079.].

Keywords: RFVT; cancer therapy; nanocarrier; riboflavin; targeting molecules; theranostic.

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.
Bartmann L, Schumacher D, von Stillfried S, Sternkopf M, Alampour-Rajabi S, van Zandvoort MAMJ, Kiessling F, Wu Z. Bartmann L, et al. Front Pharmacol. 2019 Feb 6;10:79. doi: 10.3389/fphar.2019.00079. eCollection 2019. Front Pharmacol. 2019. PMID: 30787877 Free PMC article.